StemBond Technologies is leveraging advanced materials science to transform scalable cell culture, tissue engineering and regenerative medicine. Our physics-based solutions alleviate cell culture bottlenecks experienced by those seeking to harness cell function. With precise and reproducible control over extracellular mechanics, StemBond Technologies delivers more stable cultures, less phenotypic drift and increased uniformity.
| Website | https://www.stembond.tech |
| Employees | 8 (5 on RocketReach) |
| Industry | Biotechnology |
| Keywords | Cell Culture, Tissue Engineering, Regenerative Medicine, Advanced Materials, Biomaterials, Biotechnology, Cell Therapy, 3d Cell Culture, Stem Cells, Drug Discovery, Regenerative Medicine Technologies, Bioprinting, Medical Devices, Pharmaceutical Research, Materials Science, Life Sciences, Biomanufacturing, Cell Growth |
| Competitors | Exact Sciences, Guardant Health, GRAIL, Myriad Genetics, NantHealth, Freenome, PathAI, Biocept, Inc., CancerIQ, CureMetrix +35 more (view full list) |
Looking for a particular StemBond Technologies employee's phone or email?
StemBond Technologies Questions
Andrew Hodgson is the Co-Founder CEO and Director of StemBond Technologies.
5 people are employed at StemBond Technologies.
Top StemBond Technologies Employees
-
Robert Marchmont
Fractional Chief Commercial Officer at StemBond Technologies
Cambridge, Cambridgeshire, United Kingdom1
G2Crowd Trusted
300K+
Plugin Users
